VP Business Development and Commercialization

Croom Lawrence MBA has 20+ years of experience leading commercialization for digital healthcare and precision medicine companies, including being part of AltheaDx’s 2022 exit to Castle BioSciences for $150M+ and a 10+ year veteran at Merkle/Dentsu focused on Product Launch & Customer Experience.